Back to Search Start Over

Effects of cardiac rehabilitation with and without meditation on myocardial blood flow using quantitative positron emission tomography: A pilot study.

Authors :
Bokhari S
Schneider RH
Salerno JW
Rainforth MV
Gaylord-King C
Nidich SI
Source :
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2021 Aug; Vol. 28 (4), pp. 1596-1607. Date of Electronic Publication: 2019 Sep 16.
Publication Year :
2021

Abstract

Background: Psychosocial stress is recognized as a risk factor for coronary heart disease (CHD). High rates of CHD in African-Americans may be related to psychosocial stress. However, standard cardiac rehabilitation (CR) usually does not include a systematic stress-reduction technique. Previous studies suggest that the Transcendental Meditation (TM) technique may reduce CHD risk factors and clinical events. This pilot study explored the effects of standard CR with and without TM on a measure of CHD in African-American patients.<br />Methods: Fifty-six CHD patients were assigned to CR, CR + TM, TM alone, or usual care. Testing was done at baseline and after 12 weeks. The primary outcome was myocardial flow reserve (MFR) assessed by <superscript>13</superscript> N-ammonia positron emission tomography (PET). Secondary outcomes were CHD risk factors. Based on guidelines for analysis of small pilot studies, data were analyzed for effect size (ES).<br />Results: For 37 patients who completed posttesting, there were MFR improvements in the CR + TM group (+20.7%; ES = 0.64) and the TM group alone (+12.8%; ES = 0.36). By comparison, the CR-alone and usual care groups showed modest changes (+ 5.8%; ES = 0.17 and - 10.3%; ES = - 0.31), respectively. For the combined TM group, MFR increased (+ 14%, ES = 0.56) compared to the combined non-TM group (- 2.0%, ES = - 0.08).<br />Conclusions: These pilot data suggest that adding the TM technique to standard cardiac rehabilitation or using TM alone may improve the myocardial flow reserve in African-American CHD patients. These results may be applied to the design of controlled clinical trials to definitively test these effects.<br />Trial Registration: ClinicalTrials.gov registration # NCT01810029.<br /> (© 2019. American Society of Nuclear Cardiology.)

Details

Language :
English
ISSN :
1532-6551
Volume :
28
Issue :
4
Database :
MEDLINE
Journal :
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Publication Type :
Academic Journal
Accession number :
31529385
Full Text :
https://doi.org/10.1007/s12350-019-01884-9